News

News
Diabetes News From Medical News Today
Latest Diabetes News From Medical News Today.
Successfull Completion Of Phase I Development Of In Vivo Glucose Sensing RFID Microchip VeriChip Corporation ("VeriChip") (NASDAQ:CHIP), a provider of RFID systems for healthcare and patient-related needs, and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN? chemistry platform can be applied to the development of selective binding products, announced today that a significant milestone has been achieved toward the development of an in vivo glucose-sensing RFID microchip. Study Finds HIV-Positive People Taking Some Antiretrovirals Are At Increased Risk Of Diabetes, Heart Disease HIV-positive people receiving treatment for the virus might be at an increased risk of developing heart disease and type 2 diabetes because some antiretroviral drugs can cause fat on the arms, legs, face and buttocks to move to the stomach, researchers at Australia's Garvan Institute said Monday, the News From The American Chemical Society, Nov. 19, 2008 Microcapsules act as "roach motel" to kill harmful bacteria Researchers in New Mexico and Florida are reporting development of microscopic particles that act as chemical booby traps for bacteria. The traps attract and kill up to 95 percent of nearby bacteria, including microbes responsible for worrisome hospital-based infections. The scientists describe their discovery as micro-sized "roach motels" for harmful bacteria. Diabetes I And II In Mouse Model Treated By Garlic Chemical Tablet A drug based on a chemical found in garlic can treat diabetes types I and II when taken as a tablet, a study in the new Royal Society of Chemistry journal Metallomics says. When Hiromu Sakurai and colleagues from the Suzuka University of Medical Science, Japan, gave the drug orally to type I diabetic mice, they found it reduced blood glucose levels. Genfit: New Phase I Clinical Trials With High-Dose Confirm The Excellent Tolerance Of GFT505 In Healthy Volunteers GENFIT (Alternext: ALGFT; ISIN: FR0004163111), a biopharmaceutical company at the forefront of research and development of drugs, focusing on early diagnosis and preventive treatment of cardiometabolic and neurodegenerative diseases, today announced the first data of a new Phase I clinical trials of GFT505, a drug candidate for the treatment of atherogenic dyslipidemia associated with pre-diabetes and diabetes (GFT505-1084 studies). Physicians Should Closely Monitor Elderly Patients With Kidney Damage And Look For Signs Of Organ Failure Acute kidney injury (AKI) - which is often caused by trauma, illness, or surgery - predisposes elderly individuals to the most serious form of chronic kidney disease (CKD), known as end stage renal disease (ESRD), according to a study appearing in the January 2009 issue of the Journal of the American Society Nephrology (JASN). The findings indicate that close medical follow-up is important for maintaining the health of patients who have experienced kidney damage. New Study Highlights Rising Number Of Type 2 Diabetes Patients In U.S., Increasing Complexity Of Treatments An increasing number of type 2 diabetes patients in the U.S. are being treated by a progressively complex mix of therapies, according to a study featured in Archives of Internal Medicine, a JAMA/Archives journal. The report is the first to be published by members of the Health Services Research Network (HSRN), a consortium of leading U.S. academicians that conducts independent research using IMS Health's evidence-based information to address key healthcare issues. Joint Biomarker Research Related To Insulin Resistance And Diabetes - Metabolon And Joslin Diabetes Center Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and development, and the Joslin Diabetes Center, the world's preeminent diabetes research and clinical care organization, today announced a collaboration to carry out human clinical and animal studies in the area of insulin resistance and type 2 diabetes. This collaboration agreement includes a series of studies to be conducted using Metabolon's biochemical profiling technology. Rise In Diabetes Among American Indian Youth Focus Of New National Education Program For Tribal Schools To address the growing epidemic of type 2 diabetes affecting American Indian youth, researchers from UNLV were part of a national collaboration with three federal agencies and eight tribal colleges to develop "Health is Life in Balance" - an innovative K-12 diabetes curriculum for tribal schools and schools with large American Indian/Alaska Native populations. The curriculum blends the science of diabetes with Native cultural teachings. Genetic Testing For Diabetes Type 2 Still In Its Infancy Genetic testing for type 2 diabetes is still in its infancy, said researchers who did a US study that compared risk assessment based on screening for gene variants with more traditional risk factors like weight, blood pressure and blood sugar. Diabetes Cost U.S. $218B In 2007, Report Finds Diabetes in 2007 cost the U.S. $218 billion in direct medical care and indirect costs, such as lost productivity, according to a report released on Tuesday, the AP/Raleigh News & Observer reports. For the report -- funded by Novo Nordisk, which manufactures insulin and diabetes medications -- researchers at the California Diabetes & Family Medicine Experts Respond To Study Showing Diabetes-related Costs Are $218 Billion Annually A nationally prominent expert at treating diabetes, a chronic illness with potentially serious complications including blindness, limb amputation and death, said today many complications of diabetes are preventable and family physicians play a key role in preventing and controlling the disease.